Cargando…

Successful treatment of intractable chronic spontaneous urticaria with omalizumab in a patient with ovarian cancer

Detalles Bibliográficos
Autores principales:	Hayama, Koremasa, Fujita, Hideki, Asai-Sato, Mikiko, Kawana, Kei, Terui, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Libbey Eurotext 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120768/ https://www.ncbi.nlm.nih.gov/pubmed/33459258 http://dx.doi.org/10.1684/ejd.2020.3959

Ejemplares similares

Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria
por: Endo, Takahiro, et al.
Publicado: (2020)

A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration
por: Hayama, Koremasa, et al.
Publicado: (2022)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

Improved quality of life of patients with generalized pustular psoriasis in Japan: A cross‐sectional survey
por: Hayama, Koremasa, et al.
Publicado: (2020)

Questionnaire‐based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries
por: Hayama, Koremasa, et al.
Publicado: (2020)

Overall Impairment of Quality of Life in Japanese Patients with Hidradenitis Suppurativa: Comparison with National Standard
por: HAYAMA, Koremasa, et al.
Publicado: (2022)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

Case report: Severe chronic spontaneous urticaria successfully treated with omalizumab and dupilumab
por: Puxkandl, Viktoria, et al.
Publicado: (2023)

Spitz nevus with unusual dermoscopic figures in an adult female
por: Kawana, Hironori, et al.
Publicado: (2020)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

A Novel NCSTN Gene Mutation in a Japanese Family with Hidradenitis Suppurativa
por: NISHIMORI, Nobuyuki, et al.
Publicado: (2020)

T cell activity in successful treatment of chronic urticaria with omalizumab
por: Sánchez-Machín, Inmaculada, et al.
Publicado: (2011)

Incapacitating solar urticaria: successful treatment with omalizumab
por: Kieselova, Katarina, et al.
Publicado: (2019)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
por: Metz, Martin, et al.
Publicado: (2021)

Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Omalizumab treatment for chronic spontaneous urticaria: data from Turkey
por: Kara, Rabia Oztas, et al.
Publicado: (2022)

Cost‐effectiveness of personalized omalizumab dosing for chronic spontaneous urticaria
por: Denman, Sarah, et al.
Publicado: (2022)

Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps
por: Bagnasco, Diego, et al.
Publicado: (2022)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
por: Chen, Yudi, et al.
Publicado: (2021)

Healing Effects of Omalizumab in a Patient with Cholinergic Urticaria Associated Severe Dyspeptic Complaints
por: Kutlu, Ali, et al.
Publicado: (2015)

A Case of Sporotrichosis Caused by Sporothrix globosa in Japan
por: Watanabe, Mana, et al.
Publicado: (2016)

Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
por: Metz, Martin, et al.
Publicado: (2020)

Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies
por: Ghazanfar, Misbah Nasheela, et al.
Publicado: (2015)

Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016)

EBASTINE IN CHRONIC SPONTANEOUS URTICARIA IN HIGHER DOSES
por: Godse, Kiran V
Publicado: (2011)

Changing Assessment of Diet in Chronic Spontaneous Urticaria
por: DASCHNER, Alvaro
Publicado: (2020)

Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients
por: Godse, Kiran, et al.
Publicado: (2016)

Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
por: Comberiati, Pasquale, et al.
Publicado: (2019)

Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
por: Graham, Jonathan, et al.
Publicado: (2016)

Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria
por: Diluvio, Laura, et al.
Publicado: (2020)

Response of FcεRI‐bearing leucocytes to omalizumab in chronic spontaneous urticaria
por: Alizadeh Aghdam, Mehran, et al.
Publicado: (2020)

Exploring Machine Learning Techniques to Predict the Response to Omalizumab in Chronic Spontaneous Urticaria
por: Sardina, Davide Stefano, et al.
Publicado: (2021)

Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous Urticaria
por: Ridge, Katie, et al.
Publicado: (2021)

The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment
por: Atayik, E., et al.
Publicado: (2022)

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
por: García-Gómez, Elizabeth, et al.
Publicado: (2022)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
por: Casale, Thomas B., et al.
Publicado: (2023)

Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome
por: Jeong, Soo Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6lq7t82uas8ao5t0ui79cvtdl5